Michelle L Hastings

11PUBLICATIONS
17CO-AUTHORS
Innate immunityNeurology and neuromuscular diseasesVision scienceMolecular targetsBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Nov 08, 2025
Modulating NLRP3 splicing with antisense oligonucleotides to control pathological inflammation.

Roni Klein, Janset Onyuru, Jessica L Centa

|Nov 05, 2025
Therapeutic antisense oligonucleotide mitigates retinal dysfunction in a pig model of CLN3 Batten disease.

Matthew P Stratton, Jessica L Centa, Vicki J Swier

|Jun 12, 2025
Therapeutic antisense oligonucleotide mitigates retinal dysfunction in a pig model of CLN3 Batten disease.

Matthew P Stratton, Jessica L Centa, Vicki J Swier

|Nov 25, 2024
Systematic deletion of symmetrical CFTR exons reveals new therapeutic targets for exon skipping antisense oligonucleotides.

Cecilia Pena-Rasgado, Elvia Rodriguez-Manriquez, Miroslav Dundr

|Sep 16, 2024
Modulating NLRP3 splicing with antisense oligonucleotides to control pathological inflammation.

Roni Klein, Janset Onyuru, Jessica L Centa

|Sep 10, 2024
Elevating microRNA levels by targeting biogenesis with steric-blocking antisense oligonucleotides.

Mallory A Havens, Anthony J Hinrich, Frank Rigo

Pageof 2